PTPA and glioblastoma: The overexpression of PP2A has been reported to mediate PLK dephosphorylation, resulting in G1/S phase inhibition and reduced ATP consumption under hypoxia, which contributes to the dormancy and drug resistance of glioblastoma multiforme cells 103 (Figure 2A).